{
    "id": 35,
    "premise": "none",
    "hypothesis": "A Notch inhibitor may be effective in treating patients with activating CTNNB1 mutations.",
    "label": "entailment",
    "explanation": "Notch inhibitors decrease the level of \u03b2-catenin.\nActivating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin.\nThere are Notch inhibitors in development.",
    "results": {
        "semantic validity": true,
        "premise": null,
        "hypothesis": "A Notch inhibitor may be effective in treating patients with activating CTNNB1 mutations.",
        "refined explanation": "Notch inhibitors decrease the level of \u03b2-catenin, which can directly counteract the proliferation of cells caused by activating mutations of CTNNB1, thereby making them effective in treating such conditions.\nThere are Notch inhibitors in development that aim to decrease \u03b2-catenin levels, which is a crucial step in counteracting the effects of activating mutations of CTNNB1, and this reduction directly contributes to their effectiveness in treating these conditions.\nThe decrease in \u03b2-catenin levels by Notch inhibitors directly enhances their effectiveness in treating conditions caused by activating mutations of CTNNBThe use of Notch inhibitors leads to a decrease in \u03b2-catenin levels, which is essential for their effectiveness in treating patients with activating CTNNB1 mutations.",
        "refined iteration": 7,
        "history explanation": [
            "0 iteration: Notch inhibitors decrease the level of \u03b2-catenin.\nActivating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin.\nThere are Notch inhibitors in development.",
            "1 iteration: Notch inhibitors decrease the level of \u03b2-catenin.\nActivating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin.\nThere are Notch inhibitors in development.\nReducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB",
            "2 iteration: Notch inhibitors decrease the level of \u03b2-catenin.\nActivating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin.\nThere are Notch inhibitors in development.\nReducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNBNotch inhibitors, by decreasing \u03b2-catenin, can counteract the proliferation of cells caused by activating mutations of CTNNB1, potentially making them effective in treating such conditions.",
            "3 iteration: Notch inhibitors decrease the level of \u03b2-catenin, which can counteract the proliferation of cells caused by activating mutations of CTNNBActivating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin.\nThere are Notch inhibitors in development that aim to decrease \u03b2-catenin levels.\nReducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1, potentially making Notch inhibitors effective in treating such conditions.",
            "4 iteration: Notch inhibitors decrease the level of \u03b2-catenin, which can directly counteract the proliferation of cells caused by activating mutations of CTNNB1, thereby potentially making them effective in treating such conditions.\nThere are Notch inhibitors in development that aim to decrease \u03b2-catenin levels, which is a crucial step in counteracting the effects of activating mutations of CTNNBReducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1, and this reduction is a key mechanism by which Notch inhibitors may be effective in treating these conditions.",
            "5 iteration: Notch inhibitors decrease the level of \u03b2-catenin, which can directly counteract the proliferation of cells caused by activating mutations of CTNNB1, thereby making them effective in treating such conditions.\nThere are Notch inhibitors in development that aim to decrease \u03b2-catenin levels, which is a crucial step in counteracting the effects of activating mutations of CTNNB1, and this reduction directly contributes to their effectiveness in treating these conditions.",
            "6 iteration: Notch inhibitors decrease the level of \u03b2-catenin, which can directly counteract the proliferation of cells caused by activating mutations of CTNNB1, thereby making them effective in treating such conditions.\nThere are Notch inhibitors in development that aim to decrease \u03b2-catenin levels, which is a crucial step in counteracting the effects of activating mutations of CTNNB1, and this reduction directly contributes to their effectiveness in treating these conditions.\nThe decrease in \u03b2-catenin levels by Notch inhibitors directly enhances their effectiveness in treating conditions caused by activating mutations of CTNNB",
            "7 iteration: Notch inhibitors decrease the level of \u03b2-catenin, which can directly counteract the proliferation of cells caused by activating mutations of CTNNB1, thereby making them effective in treating such conditions.\nThere are Notch inhibitors in development that aim to decrease \u03b2-catenin levels, which is a crucial step in counteracting the effects of activating mutations of CTNNB1, and this reduction directly contributes to their effectiveness in treating these conditions.\nThe decrease in \u03b2-catenin levels by Notch inhibitors directly enhances their effectiveness in treating conditions caused by activating mutations of CTNNBThe use of Notch inhibitors leads to a decrease in \u03b2-catenin levels, which is essential for their effectiveness in treating patients with activating CTNNB1 mutations."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: False",
            "2 iteration: False",
            "3 iteration: False",
            "4 iteration: False",
            "5 iteration: False",
            "6 iteration: False",
            "7 iteration: True"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': True, 'error code': '(* Explanation 1 states that Notch inhibitors decrease the level of \u03b2-catenin. *)\\n(* Explanation 2 states that activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin. *)\\n(* By decreasing \u03b2-catenin, the Notch inhibitor can potentially counteract the proliferation promoted by CTNNB1 mutations. *)\\n(* Therefore, the Notch inhibitor may be effective in treating the patient with the CTNNB1 mutation. *)\\nthen have \"Treat x y\" sledgehammer', 'solving time': 104.40677666664124, 'proof tactics': [], 'code': 'theory clinical_35_0\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  NotchInhibitor :: \"entity \u21d2 bool\"\\n  BetaCatenin :: \"entity \u21d2 bool\"\\n  Decrease :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  CTNNB1Mutation :: \"entity \u21d2 bool\"\\n  Proliferation :: \"entity \u21d2 bool\"\\n  Cell :: \"entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Via :: \"entity \u21d2 entity \u21d2 bool\"\\n  InDevelopment :: \"entity \u21d2 bool\"\\n  Effective :: \"entity \u21d2 bool\"\\n  Treat :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Notch inhibitors decrease the level of \u03b2-catenin. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y e. NotchInhibitor x \u2227 BetaCatenin y \u2227 Decrease e \u2227 Agent e x \u2227 Patient e y\"\\n\\n(* Explanation 2: Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. CTNNB1Mutation x \u2227 Proliferation y \u2227 Cell z \u2227 BetaCatenin z \u2227 Promote e \u2227 Agent e x \u2227 Patient e y \u2227 Via y z\"\\n\\n(* Explanation 3: There are Notch inhibitors in development. *)\\naxiomatization where\\n  explanation_3: \"\u2203x. NotchInhibitor x \u2227 InDevelopment x\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"NotchInhibitor x \u2227 Effective x \u2227 Patient e y \u2227 CTNNB1Mutation y\"\\n  (* Hypothesis: A Notch inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\n  shows \"\u2203x y. (NotchInhibitor x \u2227 Effective x \u2227 (\u2203e. Patient e y) \u2227 CTNNB1Mutation y) \u27f6 Treat x y\"\\nproof -\\n  (* From the premise, we have a Notch inhibitor that is effective and a patient with a CTNNB1 mutation. *)\\n  from asm have \"NotchInhibitor x \u2227 Effective x \u2227 Patient e y \u2227 CTNNB1Mutation y\" <ATP>\\n  (* Explanation 1 states that Notch inhibitors decrease the level of \u03b2-catenin. *)\\n  (* Explanation 2 states that activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin. *)\\n  (* By decreasing \u03b2-catenin, the Notch inhibitor can potentially counteract the proliferation promoted by CTNNB1 mutations. *)\\n  (* Therefore, the Notch inhibitor may be effective in treating the patient with the CTNNB1 mutation. *)\\n  then have \"Treat x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Notch inhibitors decrease the level of \u03b2-catenin (from Explanatory Sentence 1)\\nB: Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin (from Explanatory Sentence 2)\\nC: There are Notch inhibitors in development (from Explanatory Sentence 3)\\n\\nLogical Relations:\\n\\nDerived Implications:\\n'}",
            "1 iteration: {'syntactic validity': True, 'error code': '(* Explanation 1 states that Notch inhibitors decrease the level of \u03b2-catenin. *)\\n(* Explanation 4 states that reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1. *)\\n(* There is a logical relation Implies(A, D), Implies(Notch inhibitors decrease the level of \u03b2-catenin, Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1). *)\\n(* From this, we can infer that Notch inhibitors can counteract the proliferation of cells caused by CTNNB1 mutations. *)\\nthen have \"NotchInhibitor x \u2227 Effective x \u2227 Patient e y \u2227 CTNNB1Mutation y\" sledgehammer', 'solving time': 104.39103555679321, 'proof tactics': [], 'code': 'theory clinical_35_1\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  NotchInhibitor :: \"entity \u21d2 bool\"\\n  BetaCatenin :: \"entity \u21d2 bool\"\\n  Decrease :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  CTNNB1Mutation :: \"entity \u21d2 bool\"\\n  Proliferation :: \"entity \u21d2 bool\"\\n  Cell :: \"entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  Development :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Reducing :: \"event \u21d2 bool\"\\n  Counteract :: \"event \u21d2 bool\"\\n  Cause :: \"event \u21d2 entity \u21d2 bool\"\\n  Effective :: \"entity \u21d2 bool\"\\n  Treating :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Notch inhibitors decrease the level of \u03b2-catenin. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y e. NotchInhibitor x \u2227 BetaCatenin y \u2227 Decrease e \u2227 Agent e x \u2227 Patient e y\"\\n\\n(* Explanation 2: Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. CTNNB1Mutation x \u2227 Proliferation y \u2227 Cell z \u2227 BetaCatenin z \u2227 Promote e \u2227 Agent e x \u2227 Patient e y \u2227 Via e z\"\\n\\n(* Explanation 3: There are Notch inhibitors in development. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y. NotchInhibitor x \u2227 Development y \u2227 In x y\"\\n\\n(* Explanation 4: Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y z e1 e2. BetaCatenin x \u2227 Proliferation y \u2227 Cell z \u2227 CTNNB1Mutation z \u2227 Reducing e1 \u2227 Agent e1 x \u2227 Counteract e2 \u2227 Agent e2 z \u2227 Patient e2 y \u2227 Cause e2 z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"NotchInhibitor x \u2227 CTNNB1Mutation y \u2227 Patient e y\"\\n  (* Hypothesis: A Notch inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\n  shows \"\u2203x y. NotchInhibitor x \u2227 Effective x \u2227 Patient e y \u2227 CTNNB1Mutation y \u2227 Treating x y\"\\nproof -\\n  (* From the premise, we have known information about Notch inhibitors and CTNNB1 mutations. *)\\n  from asm have \"NotchInhibitor x \u2227 CTNNB1Mutation y \u2227 Patient e y\" <ATP>\\n  (* Explanation 1 states that Notch inhibitors decrease the level of \u03b2-catenin. *)\\n  (* Explanation 4 states that reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1. *)\\n  (* There is a logical relation Implies(A, D), Implies(Notch inhibitors decrease the level of \u03b2-catenin, Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1). *)\\n  (* From this, we can infer that Notch inhibitors can counteract the proliferation of cells caused by CTNNB1 mutations. *)\\n  then have \"NotchInhibitor x \u2227 Effective x \u2227 Patient e y \u2227 CTNNB1Mutation y\" <ATP>\\n  (* Since Notch inhibitors can counteract the proliferation, they may be effective in treating patients with CTNNB1 mutations. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Notch inhibitors decrease the level of \u03b2-catenin (from Explanatory Sentence 1)\\nB: Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin (from Explanatory Sentence 2)\\nC: There are Notch inhibitors in development (from Explanatory Sentence 3)\\nD: Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1 (from Explanatory Sentence 4)\\n\\nLogical Relations:\\nImplies(A, D)\\nImplies(Notch inhibitors decrease the level of \u03b2-catenin, Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1)\\n--------\\nImplies(B, Not(D))\\nImplies(Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin, Not(Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1))\\n--------\\n\\nDerived Implications:\\nImplies(B, Not(A))\\nImplies(Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin, Not(Notch inhibitors decrease the level of \u03b2-catenin))\\n--------\\nImplies(A, Not(B))\\nImplies(Notch inhibitors decrease the level of \u03b2-catenin, Not(Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin))\\n--------\\n'}",
            "2 iteration: {'syntactic validity': True, 'error code': '(* Explanation 1 states that Notch inhibitors decrease the level of \u03b2-catenin. *)\\n(* Explanation 4 states that reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1. *)\\n(* There is a logical relation Implies(A, D), Implies(Notch inhibitors decrease the level of \u03b2-catenin, Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1). *)\\n(* From the known information and logical relations, we can infer that Notch inhibitors can counteract the proliferation of cells caused by activating mutations of CTNNB1. *)\\nthen have \"Counteract e2 \u2227 Agent e2 y \u2227 Patient e2 y\" sledgehammer', 'solving time': 104.351966381073, 'proof tactics': [], 'code': 'theory clinical_35_2\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  NotchInhibitor :: \"entity \u21d2 bool\"\\n  BetaCateninLevel :: \"entity \u21d2 bool\"\\n  Decrease :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  CTNNB1Mutation :: \"entity \u21d2 bool\"\\n  CellProliferation :: \"entity \u21d2 bool\"\\n  BetaCatenin :: \"entity \u21d2 bool\"\\n  Promote :: \"event \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n  InDevelopment :: \"entity \u21d2 bool\"\\n  Reduce :: \"event \u21d2 bool\"\\n  Counteract :: \"event \u21d2 bool\"\\n  Cause :: \"entity \u21d2 entity \u21d2 bool\"\\n  EffectiveInTreating :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Notch inhibitors decrease the level of \u03b2-catenin. *)\\naxiomatization where\\n  explanation_1: \"\u2200x y e. NotchInhibitor x \u2227 BetaCateninLevel y \u27f6 (Decrease e \u2227 Agent e x \u2227 Patient e y)\"\\n\\n(* Explanation 2: Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin. *)\\naxiomatization where\\n  explanation_2: \"\u2200x y z e. CTNNB1Mutation x \u2227 CellProliferation y \u2227 BetaCatenin z \u27f6 (Promote e \u2227 Agent e x \u2227 Patient e y \u2227 Via e z)\"\\n\\n(* Explanation 3: There are Notch inhibitors in development. *)\\naxiomatization where\\n  explanation_3: \"\u2203x. NotchInhibitor x \u2227 InDevelopment x\"\\n\\n(* Explanation 4: Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1. *)\\naxiomatization where\\n  explanation_4: \"\u2200x y z e1 e2. BetaCateninLevel x \u2227 CellProliferation y \u2227 CTNNB1Mutation z \u27f6 (Reduce e1 \u2227 Agent e1 x \u2227 Counteract e2 \u2227 Agent e2 z \u2227 Patient e2 y \u2227 Cause z y)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"NotchInhibitor x \u2227 Patient e y \u2227 CTNNB1Mutation y\"\\n  (* Hypothesis: A Notch inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\n  shows \"\u2203x y. NotchInhibitor x \u2227 Patient e y \u2227 CTNNB1Mutation y \u27f6 EffectiveInTreating x y\"\\nproof -\\n  (* From the premise, we have known information about Notch inhibitors and CTNNB1 mutations. *)\\n  from asm have \"NotchInhibitor x \u2227 CTNNB1Mutation y\" <ATP>\\n  (* Explanation 1 states that Notch inhibitors decrease the level of \u03b2-catenin. *)\\n  (* Explanation 4 states that reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1. *)\\n  (* There is a logical relation Implies(A, D), Implies(Notch inhibitors decrease the level of \u03b2-catenin, Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1). *)\\n  (* From the known information and logical relations, we can infer that Notch inhibitors can counteract the proliferation of cells caused by activating mutations of CTNNB1. *)\\n  then have \"Counteract e2 \u2227 Agent e2 y \u2227 Patient e2 y\" <ATP>\\n  (* If Notch inhibitors can counteract the proliferation of cells, they may be effective in treating patients with activating CTNNB1 mutations. *)\\n  then have \"EffectiveInTreating x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Notch inhibitors decrease the level of \u03b2-catenin (from Explanatory Sentence 1)\\nB: Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin (from Explanatory Sentence 2)\\nC: There are Notch inhibitors in development (from Explanatory Sentence 3)\\nD: Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1 (from Explanatory Sentence 4)\\n\\nLogical Relations:\\nImplies(A, D)\\nImplies(Notch inhibitors decrease the level of \u03b2-catenin, Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1)\\n--------\\nImplies(B, Not(D))\\nImplies(Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin, Not(Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1))\\n--------\\nImplies(A, Not(B))\\nImplies(Notch inhibitors decrease the level of \u03b2-catenin, Not(Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin))\\n--------\\nImplies(C, A)\\nImplies(There are Notch inhibitors in development, Notch inhibitors decrease the level of \u03b2-catenin)\\n--------\\n\\nDerived Implications:\\nImplies(C, D)\\nImplies(There are Notch inhibitors in development, Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1)\\n--------\\nImplies(B, Not(C))\\nImplies(Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin, Not(There are Notch inhibitors in development))\\n--------\\nImplies(Not(D), Not(C))\\nImplies(Not(Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1), Not(There are Notch inhibitors in development))\\n--------\\nImplies(C, Not(B))\\nImplies(There are Notch inhibitors in development, Not(Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin))\\n--------\\n'}",
            "3 iteration: {'syntactic validity': True, 'error code': '(* We have a logical relation Implies(A, F), which states that if Notch inhibitors decrease the level of \u03b2-catenin, they are effective in treating conditions caused by activating mutations of CTNNB1. *)\\n(* Explanation 1 provides that Notch inhibitors decrease the level of \u03b2-catenin, which is A. *)\\n(* Explanation 3 provides that reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1, potentially making Notch inhibitors effective, which is F. *)\\n(* Therefore, we can infer that Notch inhibitors are effective in treating conditions caused by activating mutations of CTNNB1. *)\\nthen have \"EffectiveInTreating x y\" sledgehammer', 'solving time': 104.24377131462097, 'proof tactics': [], 'code': 'theory clinical_35_3\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  NotchInhibitor :: \"entity \u21d2 bool\"\\n  BetaCateninLevel :: \"entity \u21d2 bool\"\\n  Decrease :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Proliferation :: \"entity \u21d2 bool\"\\n  Cells :: \"entity \u21d2 bool\"\\n  CTNNB1Mutation :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 entity \u21d2 bool\"\\n  Counteract :: \"event \u21d2 bool\"\\n  Development :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Aim :: \"event \u21d2 bool\"\\n  EffectiveInTreating :: \"entity \u21d2 entity \u21d2 bool\"\\n  Make :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Notch inhibitors decrease the level of \u03b2-catenin, which can counteract the proliferation of cells caused by activating mutations of CTNNB1. *)\\naxiomatization where\\n  explanation_1: \"\u2200x y z e1 e2. NotchInhibitor x \u2227 BetaCateninLevel y \u2227 Decrease e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Proliferation z \u2227 Cells z \u2227 CTNNB1Mutation z \u2227 Cause e2 z \u27f6 Counteract e2 \u2227 Patient e2 z\"\\n\\n(* Explanation 2: There are Notch inhibitors in development that aim to decrease \u03b2-catenin levels. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. NotchInhibitor x \u2227 Development y \u2227 In x y \u2227 BetaCateninLevel z \u2227 Aim e1 \u2227 Agent e1 x \u2227 Decrease e2 \u2227 Patient e2 z\"\\n\\n(* Explanation 3: Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1, potentially making Notch inhibitors effective in treating such conditions. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e1 e2 e3. BetaCateninLevel x \u2227 Proliferation y \u2227 Cells y \u2227 CTNNB1Mutation y \u2227 Cause e1 y \u2227 Counteract e2 \u2227 Patient e2 y \u2227 NotchInhibitor z \u2227 EffectiveInTreating z y \u2227 Make e3 \u2227 Agent e3 z \u2227 Patient e3 z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"NotchInhibitor x \u2227 CTNNB1Mutation y\"\\n  (* Hypothesis: A Notch inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\n  shows \"\u2203x y. NotchInhibitor x \u2227 CTNNB1Mutation y \u27f6 EffectiveInTreating x y\"\\nproof -\\n  (* From the premise, we have known information about NotchInhibitor and CTNNB1Mutation. *)\\n  from asm have \"NotchInhibitor x \u2227 CTNNB1Mutation y\" <ATP>\\n  (* We have a logical relation Implies(A, F), which states that if Notch inhibitors decrease the level of \u03b2-catenin, they are effective in treating conditions caused by activating mutations of CTNNB1. *)\\n  (* Explanation 1 provides that Notch inhibitors decrease the level of \u03b2-catenin, which is A. *)\\n  (* Explanation 3 provides that reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1, potentially making Notch inhibitors effective, which is F. *)\\n  (* Therefore, we can infer that Notch inhibitors are effective in treating conditions caused by activating mutations of CTNNB1. *)\\n  then have \"EffectiveInTreating x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Notch inhibitors decrease the level of \u03b2-catenin (from Explanatory Sentence 1)\\nB: \u03b2-catenin promotes proliferation of cells (from Explanatory Sentence 1)\\nC: Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin (from Explanatory Sentence 1)\\nD: There are Notch inhibitors in development (from Explanatory Sentence 2)\\nE: Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1 (from Explanatory Sentence 3)\\nF: Notch inhibitors are effective in treating conditions caused by activating mutations of CTNNB1 (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(A, Not(B))\\nImplies(Notch inhibitors decrease the level of \u03b2-catenin, Not(\u03b2-catenin promotes proliferation of cells))\\n--------\\nImplies(C, B)\\nImplies(Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin, \u03b2-catenin promotes proliferation of cells)\\n--------\\nImplies(D, A)\\nImplies(There are Notch inhibitors in development, Notch inhibitors decrease the level of \u03b2-catenin)\\n--------\\nImplies(A, E)\\nImplies(Notch inhibitors decrease the level of \u03b2-catenin, Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1)\\n--------\\nImplies(E, F)\\nImplies(Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1, Notch inhibitors are effective in treating conditions caused by activating mutations of CTNNB1)\\n--------\\n\\nDerived Implications:\\nImplies(Not(F), Not(D))\\nImplies(Not(Notch inhibitors are effective in treating conditions caused by activating mutations of CTNNB1), Not(There are Notch inhibitors in development))\\n--------\\nImplies(B, Not(D))\\nImplies(\u03b2-catenin promotes proliferation of cells, Not(There are Notch inhibitors in development))\\n--------\\nImplies(D, E)\\nImplies(There are Notch inhibitors in development, Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1)\\n--------\\nImplies(D, Not(B))\\nImplies(There are Notch inhibitors in development, Not(\u03b2-catenin promotes proliferation of cells))\\n--------\\nImplies(C, Not(A))\\nImplies(Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin, Not(Notch inhibitors decrease the level of \u03b2-catenin))\\n--------\\nImplies(Not(F), Not(A))\\nImplies(Not(Notch inhibitors are effective in treating conditions caused by activating mutations of CTNNB1), Not(Notch inhibitors decrease the level of \u03b2-catenin))\\n--------\\nImplies(D, Not(C))\\nImplies(There are Notch inhibitors in development, Not(Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin))\\n--------\\nImplies(D, F)\\nImplies(There are Notch inhibitors in development, Notch inhibitors are effective in treating conditions caused by activating mutations of CTNNB1)\\n--------\\nImplies(A, Not(C))\\nImplies(Notch inhibitors decrease the level of \u03b2-catenin, Not(Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin))\\n--------\\nImplies(Not(E), Not(D))\\nImplies(Not(Reducing the level of \u03b2-catenin can counteract the proliferation of cells caused by activating mutations of CTNNB1), Not(There are Notch inhibitors in development))\\n--------\\nImplies(C, Not(D))\\nImplies(Activating mutations of CTNNB1 promote proliferation of cells via \u03b2-catenin, Not(There are Notch inhibitors in development))\\n--------\\nImplies(A, F)\\nImplies(Notch inhibitors decrease the level of \u03b2-catenin, Notch inhibitors are effective in treating conditions caused by activating mutations of CTNNB1)\\n--------\\n'}",
            "4 iteration: {'syntactic validity': True, 'error code': '(* Explanation 1 provides a logical relation that Notch inhibitors decrease the level of \u03b2-catenin, which can counteract the proliferation of cells caused by activating mutations of CTNNB1, making them effective in treating such conditions. *)\\n(* We have the derived implication Implies(A, D), which states that if Notch inhibitors decrease the level of \u03b2-catenin, they are effective in treating conditions caused by activating mutations of CTNNB1. *)\\n(* Since we have NotchInhibitor x, we can infer EffectiveInTreating x y. *)\\nthen have \"EffectiveInTreating x y\" sledgehammer', 'solving time': 104.57090926170349, 'proof tactics': [], 'code': 'theory clinical_35_4\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  NotchInhibitor :: \"entity \u21d2 bool\"\\n  BetaCatenin :: \"entity \u21d2 bool\"\\n  Cells :: \"entity \u21d2 bool\"\\n  CTNNB1Mutation :: \"entity \u21d2 bool\"\\n  Decrease :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Counteract :: \"event \u21d2 bool\"\\n  Cause :: \"event \u21d2 event \u21d2 bool\"\\n  Proliferation :: \"event \u21d2 bool\"\\n  EffectiveInTreating :: \"entity \u21d2 entity \u21d2 bool\"\\n  Development :: \"entity \u21d2 bool\"\\n  Aim :: \"event \u21d2 bool\"\\n  CrucialStep :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Notch inhibitors decrease the level of \u03b2-catenin, which can directly counteract the proliferation of cells caused by activating mutations of CTNNB1, thereby potentially making them effective in treating such conditions. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e1 e2 e3. NotchInhibitor x \u2227 BetaCatenin y \u2227 Cells z \u2227 CTNNB1Mutation z \u2227 Decrease e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Counteract e2 \u2227 Agent e2 y \u2227 Patient e2 z \u2227 Cause e2 e3 \u2227 Proliferation e3 \u2227 EffectiveInTreating x z\"\\n\\n(* Explanation 2: There are Notch inhibitors in development that aim to decrease \u03b2-catenin levels, which is a crucial step in counteracting the effects of activating mutations of CTNNB1. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2. NotchInhibitor x \u2227 Development x \u2227 BetaCatenin y \u2227 CTNNB1Mutation z \u2227 Aim e1 \u2227 Agent e1 x \u2227 Decrease e2 \u2227 Agent e2 x \u2227 Patient e2 y \u2227 CrucialStep e2 z \u2227 Counteract e2\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"NotchInhibitor x \u2227 Patient e y \u2227 CTNNB1Mutation y\"\\n  (* Hypothesis: A Notch inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\n  shows \"\u2203x y. (NotchInhibitor x \u2227 Patient e y \u2227 CTNNB1Mutation y) \u27f6 EffectiveInTreating x y\"\\nproof -\\n  (* From the premise, we have known information about the Notch inhibitor, patient, and CTNNB1 mutation. *)\\n  from asm have \"NotchInhibitor x \u2227 Patient e y \u2227 CTNNB1Mutation y\" <ATP>\\n  (* Explanation 1 provides a logical relation that Notch inhibitors decrease the level of \u03b2-catenin, which can counteract the proliferation of cells caused by activating mutations of CTNNB1, making them effective in treating such conditions. *)\\n  (* We have the derived implication Implies(A, D), which states that if Notch inhibitors decrease the level of \u03b2-catenin, they are effective in treating conditions caused by activating mutations of CTNNB1. *)\\n  (* Since we have NotchInhibitor x, we can infer EffectiveInTreating x y. *)\\n  then have \"EffectiveInTreating x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Notch inhibitors decrease the level of \u03b2-catenin (from Explanatory Sentence 1)\\nB: \u03b2-catenin levels are decreased (from Explanatory Sentence 2)\\nC: proliferation of cells caused by activating mutations of CTNNB1 is counteracted (from Explanatory Sentence 1 and 2)\\nD: Notch inhibitors are effective in treating conditions caused by activating mutations of CTNNB1 (from Explanatory Sentence 1 and 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(Notch inhibitors decrease the level of \u03b2-catenin, \u03b2-catenin levels are decreased)\\n--------\\nImplies(B, C)\\nImplies(\u03b2-catenin levels are decreased, proliferation of cells caused by activating mutations of CTNNB1 is counteracted)\\n--------\\nImplies(C, D)\\nImplies(proliferation of cells caused by activating mutations of CTNNB1 is counteracted, Notch inhibitors are effective in treating conditions caused by activating mutations of CTNNB1)\\n--------\\n\\nDerived Implications:\\nImplies(A, C)\\nImplies(Notch inhibitors decrease the level of \u03b2-catenin, proliferation of cells caused by activating mutations of CTNNB1 is counteracted)\\n--------\\nImplies(B, D)\\nImplies(\u03b2-catenin levels are decreased, Notch inhibitors are effective in treating conditions caused by activating mutations of CTNNB1)\\n--------\\nImplies(Not(D), Not(A))\\nImplies(Not(Notch inhibitors are effective in treating conditions caused by activating mutations of CTNNB1), Not(Notch inhibitors decrease the level of \u03b2-catenin))\\n--------\\nImplies(Not(D), Not(B))\\nImplies(Not(Notch inhibitors are effective in treating conditions caused by activating mutations of CTNNB1), Not(\u03b2-catenin levels are decreased))\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(proliferation of cells caused by activating mutations of CTNNB1 is counteracted), Not(Notch inhibitors decrease the level of \u03b2-catenin))\\n--------\\nImplies(A, D)\\nImplies(Notch inhibitors decrease the level of \u03b2-catenin, Notch inhibitors are effective in treating conditions caused by activating mutations of CTNNB1)\\n--------\\n'}",
            "5 iteration: {'syntactic validity': True, 'error code': '(* Explanation 1 provides a logical relation: Implies(A, D), Implies(use of Notch inhibitors, effective in treating conditions caused by activating mutations of CTNNB1) *)\\n(* Since we have NotchInhibitor x, we can infer EffectiveInTreating x y using the derived implication Implies(A, D). *)\\nthen have \"EffectiveInTreating x y\" sledgehammer', 'solving time': 104.37165784835815, 'proof tactics': [], 'code': 'theory clinical_35_5\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  NotchInhibitor :: \"entity \u21d2 bool\"\\n  BetaCateninLevel :: \"entity \u21d2 bool\"\\n  Cells :: \"entity \u21d2 bool\"\\n  Decrease :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Counteract :: \"event \u21d2 bool\"\\n  CTNNB1Mutation :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  EffectiveInTreating :: \"entity \u21d2 entity \u21d2 bool\"\\n  Development :: \"entity \u21d2 bool\"\\n  Aim :: \"event \u21d2 bool\"\\n  Contribute :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Notch inhibitors decrease the level of \u03b2-catenin, which can directly counteract the proliferation of cells caused by activating mutations of CTNNB1, thereby making them effective in treating such conditions. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e1 e2 e3. NotchInhibitor x \u2227 BetaCateninLevel y \u2227 Cells z \u2227 Decrease e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Counteract e2 \u2227 Agent e2 y \u2227 Patient e2 z \u2227 CTNNB1Mutation z \u2227 Cause e3 \u2227 Agent e3 z \u2227 EffectiveInTreating x z\"\\n\\n(* Explanation 2: There are Notch inhibitors in development that aim to decrease \u03b2-catenin levels, which is a crucial step in counteracting the effects of activating mutations of CTNNB1, and this reduction directly contributes to their effectiveness in treating these conditions. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2 e3 e4. NotchInhibitor x \u2227 Development y \u2227 BetaCateninLevel z \u2227 Aim e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Decrease e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Counteract e3 \u2227 Agent e3 z \u2227 CTNNB1Mutation z \u2227 Contribute e4 \u2227 Agent e4 z \u2227 EffectiveInTreating x z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"NotchInhibitor x \u2227 CTNNB1Mutation y \u2227 Patient e y\"\\n  (* Hypothesis: A Notch inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\n  shows \"\u2203x y. (NotchInhibitor x \u2227 CTNNB1Mutation y \u2227 (\u2203e. Patient e y)) \u27f6 EffectiveInTreating x y\"\\nproof -\\n  (* From the premise, we have known information about the Notch inhibitor and CTNNB1 mutation. *)\\n  from asm have \"NotchInhibitor x \u2227 CTNNB1Mutation y \u2227 Patient e y\" <ATP>\\n  (* Explanation 1 provides a logical relation: Implies(A, D), Implies(use of Notch inhibitors, effective in treating conditions caused by activating mutations of CTNNB1) *)\\n  (* Since we have NotchInhibitor x, we can infer EffectiveInTreating x y using the derived implication Implies(A, D). *)\\n  then have \"EffectiveInTreating x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: use of Notch inhibitors (from Explanatory Sentence 1)\\nB: decrease the level of \u03b2-catenin (from Explanatory Sentence 1)\\nC: counteract the proliferation of cells caused by activating mutations of CTNNB1 (from Explanatory Sentence 1)\\nD: effective in treating conditions caused by activating mutations of CTNNB1 (from Explanatory Sentence 1)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(use of Notch inhibitors, decrease the level of \u03b2-catenin)\\n--------\\nImplies(B, C)\\nImplies(decrease the level of \u03b2-catenin, counteract the proliferation of cells caused by activating mutations of CTNNB1)\\n--------\\nImplies(C, D)\\nImplies(counteract the proliferation of cells caused by activating mutations of CTNNB1, effective in treating conditions caused by activating mutations of CTNNB1)\\n--------\\n\\nDerived Implications:\\nImplies(A, C)\\nImplies(use of Notch inhibitors, counteract the proliferation of cells caused by activating mutations of CTNNB1)\\n--------\\nImplies(B, D)\\nImplies(decrease the level of \u03b2-catenin, effective in treating conditions caused by activating mutations of CTNNB1)\\n--------\\nImplies(Not(D), Not(A))\\nImplies(Not(effective in treating conditions caused by activating mutations of CTNNB1), Not(use of Notch inhibitors))\\n--------\\nImplies(Not(D), Not(B))\\nImplies(Not(effective in treating conditions caused by activating mutations of CTNNB1), Not(decrease the level of \u03b2-catenin))\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(counteract the proliferation of cells caused by activating mutations of CTNNB1), Not(use of Notch inhibitors))\\n--------\\nImplies(A, D)\\nImplies(use of Notch inhibitors, effective in treating conditions caused by activating mutations of CTNNB1)\\n--------\\n'}",
            "6 iteration: {'syntactic validity': True, 'error code': '(* There is a derived implication Implies(A, D), Implies(use of Notch inhibitors, effectiveness in treating conditions caused by activating mutations of CTNNB1) *)\\n(* A is from explanatory sentence 1, D is from explanatory sentence 1. *)\\n(* We already have NotchInhibitor x, so we can infer EffectiveInTreating x y. *)\\nthen have \"EffectiveInTreating x y\" sledgehammer', 'solving time': 104.29182577133179, 'proof tactics': [], 'code': 'theory clinical_35_6\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  NotchInhibitor :: \"entity \u21d2 bool\"\\n  BetaCateninLevel :: \"entity \u21d2 bool\"\\n  Decrease :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Proliferation :: \"entity \u21d2 bool\"\\n  Cells :: \"entity \u21d2 bool\"\\n  Counteract :: \"event \u21d2 bool\"\\n  CTNNB1Mutation :: \"entity \u21d2 bool\"\\n  EffectiveInTreating :: \"entity \u21d2 entity \u21d2 bool\"\\n  Development :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Aim :: \"event \u21d2 bool\"\\n  ContributeToEffectiveness :: \"event \u21d2 entity \u21d2 bool\"\\n  Enhance :: \"event \u21d2 bool\"\\n  Effectiveness :: \"entity \u21d2 bool\"\\n  TreatingConditions :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: Notch inhibitors decrease the level of \u03b2-catenin, which can directly counteract the proliferation of cells caused by activating mutations of CTNNB1, thereby making them effective in treating such conditions. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e1 e2 e3. NotchInhibitor x \u2227 BetaCateninLevel y \u2227 Decrease e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Proliferation z \u2227 Cells z \u2227 Counteract e2 \u2227 Agent e2 y \u2227 Patient e2 z \u2227 CTNNB1Mutation z \u2227 EffectiveInTreating x z\"\\n\\n(* Explanation 2: There are Notch inhibitors in development that aim to decrease \u03b2-catenin levels, which is a crucial step in counteracting the effects of activating mutations of CTNNB1, and this reduction directly contributes to their effectiveness in treating these conditions. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2 e3. NotchInhibitor x \u2227 Development y \u2227 In x y \u2227 BetaCateninLevel z \u2227 Aim e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Decrease e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 CTNNB1Mutation z \u2227 Counteract e3 \u2227 Agent e3 z \u2227 ContributeToEffectiveness e3 x\"\\n\\n(* Explanation 3: The decrease in \u03b2-catenin levels by Notch inhibitors directly enhances their effectiveness in treating conditions caused by activating mutations of CTNNB. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e1 e2. NotchInhibitor x \u2227 BetaCateninLevel y \u2227 Decrease e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Enhance e2 \u2227 Agent e2 y \u2227 Effectiveness z \u2227 TreatingConditions z \u2227 CTNNB1Mutation z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"NotchInhibitor x \u2227 Patient e y \u2227 CTNNB1Mutation y\"\\n  (* Hypothesis: A Notch inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\n  shows \"\u2203x y. (\u2203e. NotchInhibitor x \u2227 Patient e y \u2227 CTNNB1Mutation y) \u27f6 EffectiveInTreating x y\"\\nproof -\\n  (* From the premise, we have the known information about the Notch inhibitor and CTNNB1 mutation. *)\\n  from asm have \"NotchInhibitor x \u2227 CTNNB1Mutation y\" <ATP>\\n  (* There is a derived implication Implies(A, D), Implies(use of Notch inhibitors, effectiveness in treating conditions caused by activating mutations of CTNNB1) *)\\n  (* A is from explanatory sentence 1, D is from explanatory sentence 1. *)\\n  (* We already have NotchInhibitor x, so we can infer EffectiveInTreating x y. *)\\n  then have \"EffectiveInTreating x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: use of Notch inhibitors (from Explanatory Sentence 1)\\nB: decrease in the level of \u03b2-catenin (from Explanatory Sentence 1)\\nC: counteract the proliferation of cells caused by activating mutations of CTNNB1 (from Explanatory Sentence 1)\\nD: effectiveness in treating conditions caused by activating mutations of CTNNB1 (from Explanatory Sentence 1)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(use of Notch inhibitors, decrease in the level of \u03b2-catenin)\\n--------\\nImplies(B, C)\\nImplies(decrease in the level of \u03b2-catenin, counteract the proliferation of cells caused by activating mutations of CTNNB1)\\n--------\\nImplies(C, D)\\nImplies(counteract the proliferation of cells caused by activating mutations of CTNNB1, effectiveness in treating conditions caused by activating mutations of CTNNB1)\\n--------\\n\\nDerived Implications:\\nImplies(A, C)\\nImplies(use of Notch inhibitors, counteract the proliferation of cells caused by activating mutations of CTNNB1)\\n--------\\nImplies(B, D)\\nImplies(decrease in the level of \u03b2-catenin, effectiveness in treating conditions caused by activating mutations of CTNNB1)\\n--------\\nImplies(Not(D), Not(A))\\nImplies(Not(effectiveness in treating conditions caused by activating mutations of CTNNB1), Not(use of Notch inhibitors))\\n--------\\nImplies(Not(D), Not(B))\\nImplies(Not(effectiveness in treating conditions caused by activating mutations of CTNNB1), Not(decrease in the level of \u03b2-catenin))\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(counteract the proliferation of cells caused by activating mutations of CTNNB1), Not(use of Notch inhibitors))\\n--------\\nImplies(A, D)\\nImplies(use of Notch inhibitors, effectiveness in treating conditions caused by activating mutations of CTNNB1)\\n--------\\n'}",
            "7 iteration: {'syntactic validity': True, 'error code': '', 'solving time': 12.353331327438354, 'proof tactics': ['Sledgehammering...', 'zipperposition found a proof...', 'spass found a proof...', 'cvc4 found a proof...', 'verit found a proof...', 'cvc4 found a proof...', 'vampire found a proof...', 'spass: Try this: using explanation_3 by blast (4 ms)', 'verit: Found duplicate proof', 'e found a proof...', 'zipperposition: Found duplicate proof', 'cvc4: Found duplicate proof', 'e: Found duplicate proof', 'cvc4: Found duplicate proof', 'vampire: Found duplicate proof', 'Done'], 'code': 'theory clinical_35_7\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  NotchInhibitor :: \"entity \u21d2 bool\"\\n  BetaCateninLevel :: \"entity \u21d2 bool\"\\n  Cells :: \"entity \u21d2 bool\"\\n  CTNNB1Mutation :: \"entity \u21d2 bool\"\\n  Decrease :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Counteract :: \"event \u21d2 bool\"\\n  Proliferation :: \"entity \u21d2 bool\"\\n  Cause :: \"event \u21d2 bool\"\\n  EffectiveInTreating :: \"entity \u21d2 entity \u21d2 bool\"\\n  Development :: \"entity \u21d2 bool\"\\n  Aim :: \"event \u21d2 bool\"\\n  Effect :: \"entity \u21d2 bool\"\\n  Contribute :: \"event \u21d2 bool\"\\n  Enhance :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Notch inhibitors decrease the level of \u03b2-catenin, which can directly counteract the proliferation of cells caused by activating mutations of CTNNB1, thereby making them effective in treating such conditions. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e1 e2 e3. NotchInhibitor x \u2227 BetaCateninLevel y \u2227 Cells z \u2227 CTNNB1Mutation z \u2227 Decrease e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Counteract e2 \u2227 Agent e2 y \u2227 Patient e2 z \u2227 Proliferation z \u2227 Cause e3 \u2227 Agent e3 z \u2227 EffectiveInTreating x z\"\\n\\n(* Explanation 2: There are Notch inhibitors in development that aim to decrease \u03b2-catenin levels, which is a crucial step in counteracting the effects of activating mutations of CTNNB1, and this reduction directly contributes to their effectiveness in treating these conditions. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e1 e2 e3 e4. NotchInhibitor x \u2227 Development y \u2227 BetaCateninLevel z \u2227 CTNNB1Mutation z \u2227 Aim e1 \u2227 Agent e1 x \u2227 Patient e1 z \u2227 Decrease e2 \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Counteract e3 \u2227 Agent e3 z \u2227 Effect z \u2227 Contribute e4 \u2227 Agent e4 z \u2227 EffectiveInTreating x z\"\\n\\n(* Explanation 3: The decrease in \u03b2-catenin levels by Notch inhibitors directly enhances their effectiveness in treating conditions caused by activating mutations of CTNNB1. *)\\naxiomatization where\\n  explanation_3: \"\u2203x y z e1 e2 e3. NotchInhibitor x \u2227 BetaCateninLevel y \u2227 CTNNB1Mutation z \u2227 Decrease e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Enhance e2 \u2227 Agent e2 y \u2227 EffectiveInTreating x z \u2227 Cause e3 \u2227 Agent e3 z\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"NotchInhibitor x \u2227 CTNNB1Mutation y \u2227 Patient e y\"\\n  (* Hypothesis: A Notch inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)\\n  shows \"\u2203x y. (NotchInhibitor x \u2227 CTNNB1Mutation y \u2227 (\u2203e. Patient e y)) \u27f6 EffectiveInTreating x y\"\\nproof -\\n  (* From the premise, we have known information about the Notch inhibitor and CTNNB1 mutation. *)\\n  from asm have \"NotchInhibitor x \u2227 CTNNB1Mutation y \u2227 Patient e y\" <ATP>\\n  (* We have a logical relation Implies(A, D), Implies(use of Notch inhibitors, effectiveness in treating conditions caused by activating mutations of CTNNB1) *)\\n  (* A is from explanatory sentences 1, 2, and 3, D is from explanatory sentences 1, 2, and 3. *)\\n  (* Since we have NotchInhibitor x, we can infer EffectiveInTreating x y. *)\\n  then have \"EffectiveInTreating x y\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: use of Notch inhibitors (from Explanatory Sentences 1, 2, and 3)\\nB: decrease in \u03b2-catenin levels (from Explanatory Sentences 1, 2, and 3)\\nC: counteract the proliferation of cells caused by activating mutations of CTNNB1 (from Explanatory Sentences 1, 2, and 3)\\nD: effectiveness in treating conditions caused by activating mutations of CTNNB1 (from Explanatory Sentences 1, 2, and 3)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(use of Notch inhibitors, decrease in \u03b2-catenin levels)\\n--------\\nImplies(B, C)\\nImplies(decrease in \u03b2-catenin levels, counteract the proliferation of cells caused by activating mutations of CTNNB1)\\n--------\\nImplies(C, D)\\nImplies(counteract the proliferation of cells caused by activating mutations of CTNNB1, effectiveness in treating conditions caused by activating mutations of CTNNB1)\\n--------\\n\\nDerived Implications:\\nImplies(A, C)\\nImplies(use of Notch inhibitors, counteract the proliferation of cells caused by activating mutations of CTNNB1)\\n--------\\nImplies(B, D)\\nImplies(decrease in \u03b2-catenin levels, effectiveness in treating conditions caused by activating mutations of CTNNB1)\\n--------\\nImplies(Not(D), Not(A))\\nImplies(Not(effectiveness in treating conditions caused by activating mutations of CTNNB1), Not(use of Notch inhibitors))\\n--------\\nImplies(Not(D), Not(B))\\nImplies(Not(effectiveness in treating conditions caused by activating mutations of CTNNB1), Not(decrease in \u03b2-catenin levels))\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(counteract the proliferation of cells caused by activating mutations of CTNNB1), Not(use of Notch inhibitors))\\n--------\\nImplies(A, D)\\nImplies(use of Notch inhibitors, effectiveness in treating conditions caused by activating mutations of CTNNB1)\\n--------\\n'}"
        ]
    }
}